Abstract:Highlights • Intrathecal injection of 10 nmol NPFF potentiated morphine-induced analgesia. • Intrathecal injection of 10 pmol NPFF attenuated morphine-induced analgesia. • Both the pro- and anti-opioid effects of NPFF were mediated by NPFFR2. • Blockade of spinal NPFFR2 selectively regulated MOR agonists-induced analgesia. • NPFF exhibited anti-morphine effects in primary-cultured spinal neurons. Increasing evidence indicates that neuropeptide FF (NPFF) produces analgesic effects and augments opioid-induced analgesia at the spinal level. However, our recent research demonstrated that NPFF exerted complex opioid-modulating effects in an inflammatory pain model after intrathecal (i.t.) injection. Consistent with previous findings, we found that i.t. NPFF dose-dependently attenuated complete Freund's adjuvant-induced pain hypersensitivity. Interestingly, pharmacological results illustrated that NPFF exhibited opposite opioid-modulating effects at the spinal level depending on its administration dosage, wherein i.t. NPFF potentiated morphine-induced anti-allodynia at the dose of 10 nmol, while attenuated morphine analgesia at an ultra-low-dose of 10 pmol. Behavioral results obtained from neuropeptide FF receptor 2 (NPFFR2) knockout animals suggested that both pro- and anti-opioid effects of NPFF were mediated by NPFFR2. Moreover, these modulating effects of spinal NPFFR2 were selectively targeting mu-opioid receptor, had no effect on delta- and kappa-opioid receptor agonist-induced analgesia. Finally, the opioid-modulating effects of NPFF were further verified using in vitro calcium imaging assay, demonstrating that pretreated with NPFF in primary-cultured spinal neurons significantly attenuated the inhibitory effects of morphine on high-K + -induced neuronal excitability. Taken together, our results suggested that NPFF exhibited dual modulating effects on morphine-induced analgesia after i.t. administration, which provides a possible mechanism to explain the complex opioid-modulating effects of endogenous NPFF systems. Graphical abstract Download: Download high-res image (107KB) Download: Download full-size image

Effects of Neuropeptide FF and Related Peptides on the Antinociceptive Activities of VD-hemopressin(α) in Naive and Cannabinoid-Tolerant Mice.

Effects of Neuropeptide Ff System on Cb1 and Cb2 Receptors Mediated Antinociception in Mice

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.

Opposite Effects of Neuropeptide FF on Central Antinociception Induced by Endomorphin-1 and Endomorphin-2 in Mice.

Antinociceptive Effects of Central Administration of the Endogenous Cannabinoid Receptor Type 1 Agonist VDPVNFKLLSH-OH [(M)vd-Hemopressin(α)], an N-terminally Extended Hemopressin Peptide.

VF-13, a chimeric peptide of VD-hemopressin(α) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects

Modulation of neuropeptide FF on endomorphin-2 induced antinociception

Neuropeptide Ff Attenuates the Acquisition and the Expression of Conditioned Place Aversion to Endomorphin-2 in Mice

The dual modulating effects of neuropeptide FF on morphine-induced analgesia at the spinal level

Analgesic Tolerance and Cross-Tolerance to the Cannabinoid Receptors Ligands Hemopressin, VD-hemopressin(α) and WIN55,212-2 at the Supraspinal Level in Mice

Pharmacological Characterization of Rat VD-hemopressin(α), an Α-Hemoglobin-derived Peptide Exhibiting Cannabinoid Agonist-Like Effects in Mice

Pressor and Tachycardic Responses to Intrathecal Administration of Neuropeptide FF in Anesthetized Rats

Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice.

Peripheral and Central Sites of Action for Anti-Allodynic Activity Induced by the Bifunctional Opioid/npff Receptors Agonist BN-9 in Inflammatory Pain Model

Inhibition of Neuropeptide FF (Npff)-Induced Hypothermia and Anti-Morphine Analgesia by RF9, a New Selective NPFF Receptors Antagonist

Neuropeptide FF Prevented Histamine- or Chloroquine-Induced Acute Itch Behavior Through Non-Npff Receptors Mechanism in Male Mice

Effects of Nociceptin (13–17) in Pain Modulation at Supraspinal Level in Mice

CB1 Cannabinoid Receptor Agonist Mouse VD-hemopressin(α) Produced Supraspinal Analgesic Activity in the Preclinical Models of Pain.

BN-9, a Chimeric Peptide with Mixed Opioid and Neuropeptide FF Receptor Agonistic Properties, Produces Nontolerance-Forming Antinociception in Mice.

Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid/NPFF receptor agonist